[
  {
    "patient_ID": "TCGA.OR.A5JM",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 378,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 439,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OR.A5JM",
    "drug_therapy_name": "KETOCONAZOLE",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 378,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 439,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OR.A5JY",
    "drug_therapy_name": "CAPECITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 93,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OR.A5K2",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 298,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OR.A5K2",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 298,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OR.A5K2",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 299,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OR.A5K2",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 298,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OU.A5PI",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 239,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OU.A5PI",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 239,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OU.A5PI",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 239,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OU.A5PI",
    "drug_therapy_name": "MITOTANE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 239,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OU.A5PI",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 605,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 694,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OU.A5PI",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 605,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 694,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OU.A5PI",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 605,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 694,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OU.A5PI",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 725,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 817,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OU.A5PI",
    "drug_therapy_name": "STREPTOZOCIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 725,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 817,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.OU.A5PI",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 725,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 878,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.PK.A5HB",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 968,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1029,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  }
]
